Psychedelics
Articles
PSILOCYBIN WILL BE APPROVED BY THE END OF THIS YEAR IN THE U.S....
"In the field of drug development, Compass Pathways announced on Tuesday the six-month data from its second, larger Phase 3 clinical trial of COMP360 psilocybin for treatment-resistant depression. These new data are the latest in...
1
min.
APPROVAL OF LSD AS A SINGLE-DOSE MEDICATION IS MOVING FORWARD...
On Monday, June 22, 2026, Definium Therapeutics announced positive preliminary results from its Phase 3 study of LSD (DT120) for major depressive disorder...
0
minutes
THE FLOWERING SCHOOL HAS CONSOLIDATED ITS POSITION IN 2026 AS THE LARGEST...
Escuela FloreSiendo was co-founded by psychologist Sergio Sanz Navarro and Flor Soeiro in Barcelona in July 2022, the month in which they organized...
1
minute
TRUMP ACCELERATES LEGALIZATION OF PSILOCYBIN AND 5-MEO-DMT FOR THERAPEUTIC USE IN...
The order signed this Saturday, April 18, 2026, in the Oval Office directs that approval as drugs be expedited for those...
1
minute